Serial Number | 79285462 |
Word Mark | OPTIMAPHARM |
Filing Date | Friday, February 7, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, August 11, 2021 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Electronic publishing services, namely, publication of text and graphic works of others on recorded media and on-line featuring medical research publication of books; publication of texts, other than publicity texts; providing online publications in the nature of electronic books and journals in the field of diseases and medical and pharmaceutical research providing online electronic publications, not downloadable in the nature of diseases and medical and pharmaceutical in the field of diseases and medical and pharmaceutical research; news reporters services |
Description of Mark | The mark consists of the wording "OPTIMAPHARM" in dark blue next to a design of four circles. The circles are dark blue, dark rose, blue, and violet. The remaining white represents background or transparency only and is not claimed as a feature of the mark. |
Pseudo Mark | OPTIMA PHARM |
Indication of Colors claimed | The color(s) dark blue, blue, violet and dark rose is/are claimed as a feature of the mark. |
Goods and Services | Corporate communications services, namely, providing consultation regarding public relations communication strategies to businesses; organization of exhibitions for commercial or advertising purposes; organization of trade fairs; distribution of samples, advertising by mail order, rental of advertising time on communication media; wholesale store services for pharmaceutical, veterinary and medical preparations and supplies, retail store and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; drawing up of statements of accounts, namely, preparation of financial statements; business auditing, compilation of information into computer databases, systemization of information into computer databases; psychological testing for the selection of personnel; human resources consultancy, personnel recruitment; billing; updating and maintenance of data in computer databases; photocopying services; appointment scheduling services [office functions], business management consultancy, business management and organization consultancy, business organization consultancy, professional business consultancy, advisory services for business management; rental of office machines and equipment |
Goods and Services | Technical writing; data security consultancy; research and development of new products for others; technical research in the field of pharmaceutical studies, conducting clinical trials for others [conducting], research related to pharmaceuticals, research on the subject of pharmaceuticals, research and development for the pharmaceutical industry, research and development in the pharmaceutical and biotechnology fields, clinical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders consultancy relating to research and development in the field of therapeutics, consultancy relating to laboratory testing, consultancy in the field of pharmaceutical research, calibration services relating to medical apparatus, research and development of vaccines and medicines, pharmaceutical products research, testing of pharmaceuticals, consultancy relating to pharmacology, pharmaceutical drug development services, biological research, clinical and medical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders, medical research, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical product evaluation, conducting clinical trials for others for pharmaceutical products, conducting clinical trials for others in the field of cardiovascular disease, conducting clinical trials for others, provision of information and data relating to medical and veterinary research and development, providing information about the results of clinical trials for pharmaceutical products, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, providing scientific information in the field of medical disorders and their treatment, development of pharmaceutical preparations and medicines, pharmaceutical products development |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 15, 2020 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 15, 2020 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 15, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | OPTIMAPHARM d.d. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 09 - Joint Stock Company |
Address | HR |
Event Date | Event Description |
Monday, August 29, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, August 11, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
Thursday, August 11, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Monday, November 8, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Wednesday, October 20, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, October 20, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Wednesday, August 11, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Wednesday, August 11, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, January 25, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, January 25, 2021 | FINAL REFUSAL E-MAILED |
Monday, January 25, 2021 | FINAL REFUSAL WRITTEN |
Tuesday, December 29, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, December 29, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, December 29, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, July 18, 2020 | REFUSAL PROCESSED BY IB |
Tuesday, June 30, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, June 30, 2020 | REFUSAL PROCESSED BY MPU |
Thursday, May 28, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, May 27, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, May 19, 2020 | APPLICATION FILING RECEIPT MAILED |
Friday, May 15, 2020 | ASSIGNED TO EXAMINER |
Friday, May 15, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, May 14, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |